Filter Results:
(1,418)
Show Results For
- All HBS Web
(1,418)
- People (4)
- News (400)
- Research (814)
- Events (2)
- Multimedia (16)
- Faculty Publications (561)
Show Results For
- All HBS Web
(1,418)
- People (4)
- News (400)
- Research (814)
- Events (2)
- Multimedia (16)
- Faculty Publications (561)
- Web
Leadership - Faculty & Research
of caring for not only the corporation and shareholders but also the patients and medical professionals. How should leaders of health-related businesses weigh the demand for efficiency and profit alongside... View Details
- 20 Jun 2005
- Research & Ideas
Creating a Positive Professional Image
consulting firm. Similarly, female medical students and residents are often mistaken for nurses or orderlies and challenged by patients who do not believe they are legitimate physicians. Q: What is impression management and what are its... View Details
Keywords: by Mallory Stark
- Web
Systems Integration - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care Health Care Courses Fast Facts Value-Based Health Care... View Details
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- Profile
Soltan Bryce
in a pandemic felt like the right thing to do.”After graduation, Soltan will be joining the strategy team at Boston Medical Center as the Special Assistant to the Chief Operating Officer through the HBS Leadership Fellows Program,... View Details
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- February 2018
- Article
Maintaining Beliefs in the Face of Negative News: The Moderating Role of Experience
By: Bradley R. Staats, Diwas S. KC and F. Gino
Many models in operations management involve dynamic decision making that assumes optimal updating in response to information revelation. However, behavioral theory suggests that rather than updating their beliefs, individuals may persevere in their prior beliefs. In... View Details
Keywords: Information; Announcements; Service Operations; Decision Making; Medical Specialties; Experience and Expertise; Medical Devices and Supplies Industry
Staats, Bradley R., Diwas S. KC, and F. Gino. "Maintaining Beliefs in the Face of Negative News: The Moderating Role of Experience." Management Science 64, no. 2 (February 2018): 804–824.
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- Web
Founders & Investors - Entrepreneurship
Fouladgar-Mercer AirPR MBA 2008 Renee Fry Making Care Easier MBA 1999 Luis Garza Sada Kinedu MBA 2010 Michael Genstil VisualizeROI MBA 2002 Anthemos Georgiades Zumper MBA 2012 Paul Gibbs Folsom Labs MBA 2011 Eric Giler Scratch Wireless... View Details
- 12 Mar 2019
- First Look
New Research and Ideas, March 12, 2019
available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55802 forthcoming Journal of Medical Economics Time-Driven Activity-Based Cost Analysis for Outpatient Anticoagulation Therapy: Direct Costs in a Primary View Details
Keywords: Dina Gerdeman
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- Web
Aligning Reimbursement with Value - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care Health Care Courses Fast Facts Value-Based Health Care... View Details
- 22 May 2019
- Blog Post
What is FIELD Global Immersion?
low-income housing in India, develop new financial services for unbanked consumers in Morocco, and determine how to improve access to medical care for patients in Brazil. Once projects are proposed by... View Details
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
Harvard Medical School; the Wyss Institute at the Harvard University; and the Institute for Medical Engineering and Science (IMES) at MIT, where she engineered drug delivery systems in collaboration with... View Details
Rosabeth M. Kanter
Rosabeth Moss Kanter holds the Ernest L. Arbuckle Professorship at Harvard Business School, specializing in strategy, innovation, and leadership for change. Her strategic and practical insights guide leaders worldwide through teaching, writing, and direct... View Details
Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
- 01 Mar 2016
- First Look
March 1, 2016
this case: https://cb.hbsp.harvard.edu/cbmp/product/916414-PDF-ENG Harvard Business School Case 516-007 The Hain Celestial Group Hain Celestial manufactured natural and organic food and personal care products to be sold to retailers of... View Details
Keywords: Sean Silverthorne
- Web
Publications - Institute For Strategy And Competitiveness
value-based health care and how a motivated team can undertake a cost measurement project in their own institution. January 2020 Academic Medicine Value Based Health Care in Undergraduate View Details
- Web
ハーバード - Global
service to expand to more categories and a wider consumer segment. The company needs to decide on the features that would go into the new membership service while being careful not to cannibalize their core product. In Case B, set in... View Details
- 01 Apr 2014
- First Look
First Look: April 1
intermediary organizations. To test our theory, we examine every relationship between entrepreneurial firms and their venture capital investors in the minimally invasive surgical segment of the medical device industry over a 22-year... View Details
Keywords: Sean Silverthorne
- 14 Feb 2023
- HBS Case
Is Sweden Still 'Sweden'? A Liberal Utopia Grapples with an Identity Crisis
country is shifting away from the liberal Social Democratic Party that has been the benchmark of its system. Fewer young Swedes are joining unions, and American-style private schools and medical care have... View Details
Keywords: by Lane Lambert